Stem-Cell Transplantation
Haploidentical PBSCT based on fetomaternal tolerance feasible
Published in Blood Weekly, September 25th, 2003
According to a study from Japan, "a 31-year-old woman with advanced acute myeloid leukemia underwent non-T-cell-depleted (TCD) peripheral blood stem-cell transplantation (PBSCT) with a reduced-intensity conditioning regimen."
"The donor was an HLA haploidentical 3-loci-mismatched complementary sibling who had not inherited maternal HLA antigens," noted N. Uoshima and colleagues at Matsushita Memorial Hospital.
"Long-term fetomaternal microchimerism was detected by nested polymerase chain reaction with specific primer typing," they said....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-09-25)
More Articles from Blood Weekly
- Blood Substitute
Novel oxygen carrier does not disrupt blood cell morphology in vitro - Stem-Cell Transplantation
Umbilical cord blood transplants may be effective against neurological disorders - Atherosclerosis
Platelet-activating factor associates with the angiogenesis of arterial lesions - Bleeding Disorders
Acquired factor VIII deficiency can be treated with activated factor VII - Leukemia Therapy
Hydroxyurea improves interferon therapy for leukemia - Stem-Cell Transplantation
Immature leukocyte monitoring may aid PBSC harvest - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
